Definitive Contract W81XWH16C0183
Award Date 9/28/16
Potential Completion Date 2/27/19
Potential Value $1M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- This is a $150,000.00 firm fixed-price definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract has a period of performance ending on March 30, 2016. Nanocomposix has provided similar products and services to the Department of Health and Human Services and Department of Defense in the past, including lateral flow assay devices, gold nanoparticles, and research and development for...
- This is a Small Business Innovation Research (SBIR) Phase I contract award to Nanocomposix, Inc. by the U.S. Army Medical Command (MEDCOM) for the development of new biomedical technologies. The contract has a firm fixed price of $150,000.00 and a period of performance through March 25, 2017. Nanocomposix, a manufacturer of engineered nanoparticles, has previously received prime federal contracts and grants from agencies such as the Department of Health and Human Services and Department of...
- This is a Phase I Small Business Technology Transfer (STTR) contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Nanocomposix, Inc., a for-profit manufacturer of engineered nanoparticles. The $150,000.00 firm fixed price contract was awarded on June 23, 2017 with a completion date of March 31, 2018. Nanocomposix has previously received prime federal contracts from agencies such as the Department of Health and Human Services and...
- Nanocomposix, Inc. was awarded a firm fixed price definitive contract valued at one hundred fifty thousand dollars by the Department of the Army Medical Command. This small business set aside award is in response to SBIR Phase I Proposal #A123-116-0217 to provide research and development services. As a manufacturer of precisely engineered nanoparticles, Nanocomposix will likely utilize its expertise and capabilities to support the Medical Command's biomedical technology initiatives. Previous...
- The Department of the Army Materiel Command Research Development and Engineering Command awarded a $167,500.00 Firm Fixed Price contract to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles, to develop drying processes for producing high aspect ratio conductive flakes using physical vapor deposition. This Small Business Innovation Research (SBIR) Program Phase I action contract was awarded on May 19, 2020, with a completion date of March 19, 2021. Nanocomposix has...
- This firm fixed price purchase order contract, awarded by the Centers for Disease Control and Prevention (CDC) to Nanocomposix, Inc., is for $150,000.00 and is for research and development under the Small Business Innovation Research (SBIR) program. The contract is not set aside for a specific business type. Nanocomposix is a small business that manufactures engineered nanoparticles and has previously performed prime contracts and subcontractor work for the National Institutes of Health, Food...
- <p>This is a $750,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the Department of the Air Force Materiel Command to Nanocomposix, Inc., a manufacturer of engineered nanoparticles, for the development of passive nanoparticle coatings. Nanocomposix has previously provided products and services to other federal agencies such as the Department of Health and Human Services and the Department of Defense. This contract is set aside for small businesses.</p>
- This SBIR Phase II contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The $997,267 cost-plus-fixed-fee contract is for the development of "bright, photostable surface enhanced fluorescent nanotags" to advance biomedical technologies. Nanocomposix has previously provided products and R&D services to NCI, FDA, CDC, and the...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Nanocomposix, Inc. The $200,000.00 fixed-price contract is for the development of "Surface Enhanced Fluorescence Nanotags for Ultrasensitive Multiplexed Assay Systems." As a small business manufacturer of engineered nanoparticles, Nanocomposix has previously received prime federal contracts and...
- This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The $100,000.00 firm-fixed-price contract is for the development of a bio-templating method to synthesize high-conductivity, infrared obscuration nanorods. Nanocomposix has prior experience as a prime and subcontractor on federal contracts and grants, primarily with...
This is a $999,999.99 cost-plus-fixed-fee contract awarded by the U.S. Army Medical Command (MEDCOM) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract is for a Small Business Innovation Research (SBIR) Phase II program with a target completion date of February 27, 2019. Nanocomposix has previously supported the Department of Defense and Department of Health and Human Services through prime federal contracts and subcontracts, delivering products and services for biomedical applications such as diagnostics and vaccine development. This contract provides funding for Nanocomposix to continue researching and developing their nanoparticle technologies under the SBIR program.
Generated 4/1/25, 6:04 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 12/22/16 | |
| Not listed | Not listed | $1.0m | 9/20/16 |